#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA650218	F	Beta-blocking activity measured by applying the stepwise linear discriminate analysis; Inactive		48		assay format	Scientific Literature
2.	ALA1794401	F	PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962]		91,504		assay format	PubChem BioAssays
3.	ALA1794424	F	PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771]		30,565		assay format	PubChem BioAssays
4.	ALA2114738	F	PubChem BioAssay. qHTS for Inhibitors of Glutaminase (GLS). (Class of assay: confirmatory)	Homo sapiens	15,494		assay format	PubChem BioAssays
5.	ALA2114780	F	PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory)	Homo sapiens	58,727		cell-based format	PubChem BioAssays
6.	ALA2077180	F	TP_TRANSPORTER: inhibition of PAH uptake (PAH: 5 uM, Oxytetracycline: 500 uM) in OAT1-expressing S2 cells		1		cell-based format	TP-search Transporter Database
7.	ALA2075461	F	TP_TRANSPORTER: inhibition of PGF2alpha uptake (PGF2alpha: 0.005 uM, Oxytetracycline: 5 uM) in OAT2-expressing S2 cells		1		cell-based format	TP-search Transporter Database
8.	ALA2076661	F	TP_TRANSPORTER: inhibition of E1S uptake (E1S: 0.05 uM, Oxytetracycline: 50 uM) in OAT3-expressing S2 cells		1		cell-based format	TP-search Transporter Database
9.	ALA1909163	B	DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4)	Cavia porcellus	871		tissue-based format	DrugMatrix
10.	ALA1909164	B	DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4)		871		cell membrane format	DrugMatrix
11.	ALA1909165	B	DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid)	Oryctolagus cuniculus	871		tissue-based format	DrugMatrix
12.	ALA1909166	B	DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH)		871		cell membrane format	DrugMatrix
13.	ALA1909167	B	DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH)		871		cell membrane format	DrugMatrix
14.	ALA1909168	B	DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH)		871		cell membrane format	DrugMatrix
15.	ALA1909169	B	DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine)		871		cell-based format	DrugMatrix
16.	ALA1909170	B	DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine)		871		cell membrane format	DrugMatrix
17.	ALA1909171	B	DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine)		871		cell membrane format	DrugMatrix
18.	ALA1909172	B	DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine)		871		cell membrane format	DrugMatrix
19.	ALA1909173	B	DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine)		871		cell membrane format	DrugMatrix
20.	ALA1909174	B	DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine)		871		cell membrane format	DrugMatrix